TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
PharmaLogic Consulting AB
Closing information (x1000 NOK)
Closing information | 2024/09 | 2023/09 | 2022/09 |
Turnover |
4,603
|
198 | |
Financial expenses |
0
|
218 | |
Earnings before taxes |
3,526
|
-1,170 | |
EBITDA |
3,430
|
-953 | |
Total assets |
9,980
|
8,490 | |
Current assets |
8,338
|
6,923 | |
Current liabilities |
1,170
|
322 | |
Equity capital |
8,745
|
7,714 | |
- share capital |
49
|
48 | |
Employees (average) |
1
![]() |
1
![]() |
1 |
Financial ratios
Fiscal year | 2024/09 | 2023/09 | 2022/09 |
Solvency |
87.6%
|
90.9% | |
Turnover per employee |
4,603
|
198 | |
Profit as a percentage of turnover |
76.6%
|
-590.9% | |
Return on assets (ROA) |
35.3%
|
-11.2% | |
Current ratio |
712.6%
|
2150.0% | |
Return on equity (ROE) |
40.3%
|
-15.2% | |
Change turnover |
4,401
|
-2,428 | |
Change turnover % |
-95%
|
2180%
|
-92% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2024/09 | 2023/09 | 2022/09 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.